Supplementary Figure 1 from Cetuximab Reverses the Warburg Effect by Inhibiting HIF-1–Regulated LDH-A

Haiquan Lu,Xinqun Li,Zhongguang Luo,Jie Liu,Zhen Fan

DOI: https://doi.org/10.1158/1535-7163.22497433.v1

2023-01-01

Abstract:PDF - 218KB, Knockdown of LDH-A overcame resistance to cetuximab-induced cell cycle arrest.

What problem does this paper attempt to address?

Supplementary Figure 2 from Cetuximab Reverses the Warburg Effect by Inhibiting HIF-1–Regulated LDH-A

Haiquan Lu,Xinqun Li,Zhongguang Luo,Jie Liu,Fan Zhao

DOI: https://doi.org/10.1158/1535-7163.22497430

2023-01-01

Abstract:PDF - 190KB, Combination of oxamate and cetuximab induces growth inhibition in cetuximab-resistant HNSCC cells.
Data from Cetuximab Reverses the Warburg Effect by Inhibiting HIF-1–Regulated LDH-A

Haiquan Lu,Xinqun Li,Zhongguang Luo,Jie Liu,Zhen Fan

DOI: https://doi.org/10.1158/1535-7163.mct-12-1245

2023-01-01

Abstract:Abstract Hypoxia-inducible factor-1 (HIF-1) plays a critical role in reprogramming cancer metabolism toward aerobic glycolysis (i.e., the Warburg effect), which is critical to supplying cancer cells with the biomass needed for proliferation. Previous studies have shown that cetuximab, an EGF receptor–blocking monoclonal antibody, downregulates the alpha subunit of HIF-1 (HIF-1α) through the inhibition of EGF receptor downstream cell signaling and that downregulation of HIF-1α is required for cetuximab-induced antiproliferative effects. However, the mechanism underlying these actions has yet to be identified. In this study, we used the Seahorse XF96 extracellular flux analyzer to assess the effect of cetuximab treatment on changes in glycolysis and mitochondrial respiration, the two major energy-producing pathways, in live cells. We found that cetuximab downregulated lactate dehydrogenase A (LDH-A) and inhibited glycolysis in cetuximab-sensitive head and neck squamous cell carcinoma (HNSCC) cells in an HIF-1α downregulation–dependent manner. HNSCC cells with acquired cetuximab resistance expressed a high level of HIF-1α and were highly glycolytic. Overexpression of a HIF-1α mutant (HIF-1α/ΔODD) conferred resistance to cetuximab-induced G1 phase cell-cycle arrest, which could be overcome by knockdown of LDH-A expression. Inhibition of LDH-A activity with oxamate enhanced the response of cetuximab-resistant cells to cetuximab. Cetuximab had no noticeable inhibitory effect on glycolysis in nontransformed cells. These findings provide novel mechanistic insights into cetuximab-induced cell-cycle arrest from the perspective of cancer metabolism and suggest novel strategies for enhancing cetuximab response. Mol Cancer Ther; 12(10); 2187–99. ©2013 AACR.
Supplementary Figure 3 from an Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl As a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Lauren Averett Byers,Lixia Diao,Jing Wang,Pierre Saintigny,Luc Girard,Michael Peyton,Li Shen,Youhong Fan,Uma Giri,Praveen K. Tumula,Monique B. Nilsson,Jayanthi Gudikote,Hai Tran,Robert J.G. Cardnell,David J. Bearss,Steven L. Warner,Jason M. Foulks,Steven B. Kanner,Varsha Gandhi,Nancy Krett,Steven T. Rosen,Edward S. Kim,Roy S. Herbst,George R. Blumenschein,J. Jack Lee,Scott M. Lippman,K. Kian Ang,Gordon B. Mills,Waun K. Hong,John N. Weinstein,Ignacio I. Wistuba,Kevin R. Coombes,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/1078-0432.22446704

2023-01-01

Abstract:PDF file - 66K, CDH1 probes vary in their accuracy and dynamic range
Supplementary Figure 8 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Wen Liu,Benjamin H. Beck,Kedar S. Vaidya,Kevin T. Nash,Kyle P. Feeley,Scott W. Ballinger,Keke M. Pounds,Warren L. Denning,Anne R. Diers,Aimee Landar,Animesh Dhar,Tomoo Iwakuma,Danny R. Welch

DOI: https://doi.org/10.1158/0008-5472.22400874.v1

2023-01-01

Abstract:PDF file - 2389K, Supplemental Figure 8. C8161.9 cell growth depends upon glucose, but not glutamine. C8161.9Vector (V), C8161.9KFMΔSS, C8161.9KFM and C8161.9KFM/shPGC1α (KFM shP) cells were cultured in 0.1% fetal bovine serum-containing DMEM in the presence (+) or absence (-) of glucose or L-glutamine for 10 days. Representative images of the cell cultures are shown.
Supplementary Figure 1 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Wen Liu,Benjamin H. Beck,Kedar S. Vaidya,Kevin T. Nash,Kyle P. Feeley,Scott W. Ballinger,Keke M. Pounds,Warren L. Denning,Anne R. Diers,Aimee Landar,Animesh Dhar,Tomoo Iwakuma,Danny R. Welch

DOI: https://doi.org/10.1158/0008-5472.22400895

2023-01-01

Abstract:PDF file - 1136K, Supplemental Figure 1. Glycolytic enzyme expression in KISS1-expressing cells. Transcript level of glucose transporter (GLUT1) and several glycolytic enzymes (HKII, PFK1, PKM1, PKM2, LDHA and LDHB) were examined by qRT-PCR in C8161.9Vector (V), C8161.9KFMdeltaSS (D) and C8161.9KFM (K) as well as MelJuSoVector (V) and MelJuSoKFM (K) cells. Values are mean plus-minus standard deviation of three independent experiments. P values are based on a two-sided Student's T-test (*, p<0.05; **, p<0.01; ***, p<0.001).
Supplementary Figure 2 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Wen Liu,Benjamin H. Beck,Kedar S. Vaidya,Kevin T. Nash,Kyle P. Feeley,Scott W. Ballinger,Keke M. Pounds,Warren L. Denning,Anne R. Diers,Aimee Landar,Animesh Dhar,Tomoo Iwakuma,Danny R. Welch

DOI: https://doi.org/10.1158/0008-5472.22400892

2023-01-01

Abstract:PDF file - 1288K, Supplemental Figure 2. A, Conditioned media from C8161.9KFM but not C8161.9 cells downregulates vATPase expression. C8161.9Vector cells were treated with conditioned media collected from C8161.9Vector , C8161.9KFM, and C8161.9 cells for 24 hours. The expression of v-ATPase subunit V0D2 and V1G3 in C8161.9Vector, C8161.9KFM, and C8161.9 cells were then examined by qRT-PCR. Values are means plus-minus SD of triplicate measurements. P values are based on a twosided Student's test. B, Transcript levels of apoptotic genes (BNIP3 and ATG5) and glycolytic genes (GLUT1, HKII, PFK1) were examined by qRT-PCR in C8161.9Vector (V), C8161.9KFMdeltaSS (D) and C8161.9KFM (K) cells treated with bafilomycin (10 nM; 24 hr). Values are mean plus-minus standard deviation for triplicate samples. P values are based upon two-sided Student's T-test (*, p<0.05; **, p<0.01; ***, p<0.001).
The effects of cetuximab in combination with docetaxel for the acquired resistance to EGFR-TKI in non-small cell lung cancer cells

Ling ZHANG,Xue-fei LI,Liang TANG,Yin-min ZHAO,Cai-cun ZHOU

DOI: https://doi.org/10.3781/j.issn.1000-7431.2014.07.002

2014-01-01

Tumori

Abstract:Objective: To investigate the effects of cetuximab in combination with docetaxel on the acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in non-small cell lung cancer PC9/G2 cells in vitro and in vivo. Methods: The PC9/G2 cells were treated with different concentrations of cetuximab and docetaxel alone and in combination, and then the proliferation of PC9/G2 cells was detected by MTT assay and the half inhibitory concentration (IC50) values were calculated. After the PC9/G2 cells treatment with 40 μg/mL cetuximab and 25 μmol/L docetaxel alone and in combination, the apoptosis of PC9/G2 cells was measured by flow cytometry, then the expression levels of EGFR and EGFR pTyr1173, pTyr1086 and pTyr845 proteins were determined by Western blotting. The tumor xenograft of PC9/G2 cells in nude mice was established. Intraperitoneal injection of cetuximab (10 mg/kg) and docetaxel (40 mg/kg) alone and in combination was performed, and the growth of tumor xenograft was observed. Results: The IC50 value of cetuximab in combination with docetaxel in PC9/G2 cells was lower than those of cetuximab and docetaxel alone (P 0.05). The growth inhibition rate of tumor xenograft of PC9/G2 cells in nude mice treated with cetuximab in combination with docetaxel was higher than those treated with cetuximab and docetaxel alone (P < 0.01). Conclusion: Cetuximab in combination with docetaxel can inhibit the proliferation of PC9/G2 cells in vitro and in vivo. DOI:10.3781/j.issn.1000-7431.2014.07.002
Supplementary Figure 3 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Wen Liu,Benjamin H. Beck,Kedar S. Vaidya,Kevin T. Nash,Kyle P. Feeley,Scott W. Ballinger,Keke M. Pounds,Warren L. Denning,Anne R. Diers,Aimee Landar,Animesh Dhar,Tomoo Iwakuma,Danny R. Welch

DOI: https://doi.org/10.1158/0008-5472.22400889

2023-01-01

Abstract:PDF file - 1108K, Supplemental Figure 3. KISS1 enhances mitochondria gene expression. C8161.9Vector, C8161.9KFM, and C8161.9 cells were subjected to mitochondria gene profiling by Mitochondria PCR Array. Selected genes up-regulated (Blue) and down-regulated (Yellow) in C8161.9KFM were shown as in the table.
Supplementary Figure 7 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Wen Liu,Benjamin H. Beck,Kedar S. Vaidya,Kevin T. Nash,Kyle P. Feeley,Scott W. Ballinger,Keke M. Pounds,Warren L. Denning,Anne R. Diers,Aimee Landar,Animesh Dhar,Tomoo Iwakuma,Danny R. Welch

DOI: https://doi.org/10.1158/0008-5472.22400877

2023-01-01

Abstract:PDF file - 1105K, Supplemental Figure 7. KISS1 inhibits glucose uptake and activation of AMPK. A, Glucose uptake by C8161.9Vector (Vec), C8161.9KFMΔSS, C8161.9KFM and C8161.9KFM/shPGC1α cells was measured using 2-deoxyglucose uptake and normalized to total protein. B, C8161.9Vector, C8161.9KFM and C8161.9KFMdeltaSS cells were treated with AICAR followed by Western blot with antibodies for AMPK, phospho-AMPK (Thr172), mTOR , phospho-mTOR (Ser2448), KISS1 and GAPDH.
Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non–Small Cell Lung Cancer

Viviana De Rosa,Francesca Iommelli,Marcello Monti,Rosa Fonti,Giuseppina Votta,Maria Patrizia Stoppelli,Silvana Del Vecchio

DOI: https://doi.org/10.1158/1078-0432.ccr-15-0375

IF: 13.801

2015-07-27

Clinical Cancer Research

Abstract:PURPOSE: One of the hallmarks of cancer cells is the excessive conversion of glucose to lactate under normoxic conditions, also known as the Warburg effect. Here, we tested whether the targeted inhibition of EGFR may revert this effect and reactivate mitochondrial oxidative phosphorylation in non-small cell lung cancer (NSCLC).EXPERIMENTAL DESIGN: Sensitive (HCC827) and resistant (H1975 and H1993) NSCLC cells were treated with a panel of EGFR or MET inhibitors, and then tested for changes of EGFR signaling, glycolytic cascade, and mitochondrial function. Silencing of key glycolytic enzymes was then performed with targeted siRNAs. Furthermore, tumor-bearing nude mice treated with EGFR inhibitors were evaluated with (18)F-FDG PET/CT and tumors were analyzed for glycolytic and mitochondrial proteins.RESULTS: Effective inhibition of EGFR signaling in NSCLC cells induced a dramatic reduction of hexokinase II (HKII) and phospho-pyruvate kinase M2 (p-PKM2, Tyr105) levels as well as an upregulation of mitochondrial complexes subunits (OXPHOS). Accordingly, a decreased lactate secretion and increased intracellular ATP levels were also observed in response to EGFR inhibitors. Downregulation of HKII and PKM2 by targeted siRNA transfection did not cause upregulation of OXPHOS but enhanced the effects of EGFR TKIs. Conversely, selective inhibition of AKT and ERK1/2 caused OXPHOS upregulation and glycolysis inhibition, respectively. Similar findings were obtained in tumors from animals treated with appropriate EGFR inhibitors.CONCLUSIONS: Our findings indicate that EGFR inhibitors may reactivate oxidative phosphorylation of cancer cells and provide a mechanistic clue for the rational combination of agents targeting EGFR-dependent proliferation and glucose metabolism in cancer therapy.

oncology
Supplementary Figures 1-6 from Combined EGFR/MET or EGFR/HSP90 Inhibition is Effective in the Treatment of Lung Cancers Codriven by Mutant EGFR Containing T790M and MET

Lu Xu,Eiki Kikuchi,Chunxiao Xu,Hiromichi Ebi,Dalia Ercan,Katherine A. Cheng,Robert Padera,Jeffrey A. Engelman,Pasi A. Jänne,Geoffrey I. Shapiro,Takeshi Shimamura,Kwok-Kin Wong

DOI: https://doi.org/10.1158/0008-5472.22391819.v1

2023-01-01

Abstract:PDF file - 1.4MB, Supplemental Figure 1. MET is inducible in MET, TD/MET, and TL/MET models Supplemental Figure 2. Quantification of hMET expression in mouse models Supplemental Figure 3. Comparison of the tumor counts in mutant EGFR lung tumors with or without expression of hMET. Supplemental Figure 4. Representative MRI images prior to and after treatment in TL and TL/MET mice. Supplemental Figure 5. Xenografts of HCC827GR6 cells ectopically expressing EGFR E746_A750del/T790M are sensitive to the combination of WZ4002 and 17-DMAG. Supplemental Figure 6. The WZ4002/crizotinib or WZ4002/17-DMAG combinations suppress phosphorylation of EGFR, Akt, and Erk in TD and TD/MET to a greater extent than individual treatments
Supplementary Figure 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401690

2023-01-01

Abstract:PDF file - 623K, Effects of restoring HIC1 expression in MDA-468 cells.
Supplementary Figure 5 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Wen Liu,Benjamin H. Beck,Kedar S. Vaidya,Kevin T. Nash,Kyle P. Feeley,Scott W. Ballinger,Keke M. Pounds,Warren L. Denning,Anne R. Diers,Aimee Landar,Animesh Dhar,Tomoo Iwakuma,Danny R. Welch

DOI: https://doi.org/10.1158/0008-5472.22400883

2023-01-01

Abstract:PDF file - 753K, Supplemental Figure 5. Knocking down PGC1alpha expression abolished KISS1-mediated increase of mitochondria gene expression. The expression of mtTFA, , MT-ND2, MT-RNR2 and nuclear encoded mitochondria genes AIFM2, RHOT1 and TIMM8 in C8161.9Vector (V), C8161.9KFM (P), and C8161.9KFMshPGC1alpha (clones 1-1 and 1-2) were examined by qRT-PCR. Values are mean plus-minus SD of triplicate measurements. P values are based upon a two-sided Student's T-test.
Supplementary Figure 4 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Wen Liu,Benjamin H. Beck,Kedar S. Vaidya,Kevin T. Nash,Kyle P. Feeley,Scott W. Ballinger,Keke M. Pounds,Warren L. Denning,Anne R. Diers,Aimee Landar,Animesh Dhar,Tomoo Iwakuma,Danny R. Welch

DOI: https://doi.org/10.1158/0008-5472.22400886

2023-01-01

Abstract:PDF file - 968K, Supplemental Figure 4. KISS1 differentially regualtes PGC1alpha downstream of lipid signals. Expression of genes in lipogenesis and β-oxidation in C8161.9Vector (V), C8161.9KFMΔSS and C8161.9KFM (KFM clones 59 and 17 are shown), C8161.9KFM/shKiss1 (clones IA1, IA4 and IE4) cells were examined by by qRT-PCR. Values are means plus-minus SD of triplicate measurements. P values are based on a two-sided Student's test.
Supplementary Figure 6 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401675

2023-01-01

Abstract:PDF file - 142K, The AKT signaling pathway is partly inactivated after NGALR knockdown.
Supplementary Figure S9 from Inhibition of P70s6k1 Activation by Pdcd4 Overcomes the Resistance to an IGF-1R/IR Inhibitor in Colon Carcinoma Cells

Yan Zhang,Qing Wang,Li Chen,Huiling Yang

DOI: https://doi.org/10.1158/1535-7163.22502895

2023-01-01

Abstract:Supplementary Figure S9: Semi-quantitative analyses of the Western blot result of HCT116 cells in Fig. 5E
Supplementary Figure 8 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401669.v1

2023-01-01

Abstract:PDF file - 344K, Endogenous HIC1 knockdown promotes cell migration and invasion in MCF-10A cells.
Supplementary Figure 3 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer

Darren A.E. Cross,Susan E. Ashton,Serban Ghiorghiu,Cath Eberlein,Caroline A. Nebhan,Paula J. Spitzler,Jonathon P. Orme,M. Raymond V. Finlay,Richard A. Ward,Martine J. Mellor,Gareth Hughes,Amar Rahi,Vivien N. Jacobs,Monica Red Brewer,Eiki Ichihara,Jing Sun,Hailing Jin,Peter Ballard,Katherine Al-Kadhimi,Rachel Rowlinson,Teresa Klinowska,Graham H.P. Richmond,Mireille Cantarini,Dong-Wan Kim,Malcolm R. Ranson,William Pao

DOI: https://doi.org/10.1158/2159-8290.22532204

2023-01-01

Abstract:PDF file - 235KB, Activity of AZD9291 and metabolites against rare EGFR mutations using cellular phosphorylation assays.
Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401678

2023-01-01

Abstract:PDF file - 570K, LCN2 promotes lung metastasis in balb/c nude mice.

Supplementary Figure 1 from Cetuximab Reverses the Warburg Effect by Inhibiting HIF-1–Regulated LDH-A

Supplementary Figure 2 from Cetuximab Reverses the Warburg Effect by Inhibiting HIF-1–Regulated LDH-A

Data from Cetuximab Reverses the Warburg Effect by Inhibiting HIF-1–Regulated LDH-A

Supplementary Figure 3 from an Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl As a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Supplementary Figure 8 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Supplementary Figure 1 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Supplementary Figure 2 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

The effects of cetuximab in combination with docetaxel for the acquired resistance to EGFR-TKI in non-small cell lung cancer cells

Supplementary Figure 3 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Supplementary Figure 7 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non–Small Cell Lung Cancer

Supplementary Figures 1-6 from Combined EGFR/MET or EGFR/HSP90 Inhibition is Effective in the Treatment of Lung Cancers Codriven by Mutant EGFR Containing T790M and MET

Supplementary Figure 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 5 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Supplementary Figure 4 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Supplementary Figure 6 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure S9 from Inhibition of P70s6k1 Activation by Pdcd4 Overcomes the Resistance to an IGF-1R/IR Inhibitor in Colon Carcinoma Cells

Supplementary Figure 8 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 3 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer

Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2